Jacky Luiten

General discussion and future perspectives | 139 9 39. Langhans L, Tvedskov TF, Klausen TL, Jensen MB, Talman ML, Vejborg I, et al. Radioactive Seed Localization or Wire ‐ guided Localization of Nonpalpable Invasive and In Situ Breast Cancer: A Randomized, Multicenter, Open ‐ label Trial. Ann Surg. 2017;266(1):29 ‐ 35. 40. Wang GL, Tsikouras P, Zuo HQ, Huang MQ, Peng L, Bothou A, et al. Radioactive seed localization and wire guided localization in breast cancer: A systematic review and meta ‐ analysis. J BUON. 2019;24(1):48 ‐ 60. 41. Langhans L, Klausen TL, Tvedskov TF, Talman ML, Oturai PS, Vejborg I, et al. Preparation and Administration of I ‐ 125 Labeled Seeds for Localization of Nonpalpable Breast Lesions. Curr Radiopharm. 2016;9(2):143 ‐ 149. 42. Harvey JR, Lim Y, Murphy J, Howe M, Morris J, Goyal A, et al. Safety and feasibility of breast lesion localization using magnetic seeds (Magseed): a multi ‐ centre, open ‐ label cohort study. Breast Cancer Res Treat. 2018;169(3):531 ‐ 536. 43. Donker M, Litiere S, Werutsky G, Julien JP, Fentiman IS, Agresti R, et al. Breast ‐ conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15 ‐ year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial. J Clin Oncol. 2013;31(32):4054 ‐ 4059. 44. Cuzick J, Sestak I, Pinder SE, Ellis IO, Forsyth S, Bundred NJ, et al. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long ‐ term results from the UK/ANZ DCIS trial. Lancet Oncol. 2011;12(1):21 ‐ 29. 45. Wapnir IL, Dignam JJ, Fisher B, Mamounas EP, Anderson SJ, Julian TB, et al. Long ‐ term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B ‐ 17 and B ‐ 24 randomized clinical trials for DCIS. J Natl Cancer Inst. 2011;103(6):478 ‐ 488. 46. Warnberg F, Garmo H, Emdin S, Hedberg V, Adwall L, Sandelin K, et al. Effect of radiotherapy after breast ‐ conserving surgery for ductal carcinoma in situ: 20 years follow ‐ up in the randomized SweDCIS Trial. J Clin Oncol. 2014;32(32):3613 ‐ 3618. 47. Correa C, McGale P, Taylor C, Wang Y, Clarke M, Davies C, et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr. 2010;2010(41):162 ‐ 177. 48. Silverstein MJ. An argument against routine use of radiotherapy for ductal carcinoma in situ. Oncology (Williston Park). 2003;17(11):1511 ‐ 1533; discussion 1533 ‐ 1514, 1539, 1542 passim. 49. Sagara Y, Freedman RA, Vaz ‐ Luis I, Mallory MA, Wong SM, Aydogan F, et al. Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast ‐ Conserving Surgery for Ductal Carcinoma In Situ: A Population ‐ Based Longitudinal Cohort Study. J Clin Oncol. 2016;34(11):1190 ‐ 1196. 50. van Maaren MC, Lagendijk M, Tilanus ‐ Linthorst MMA, de Munck L, Pijnappel RM, Schmidt MK, et al. Breast cancer ‐ related deaths according to grade in ductal carcinoma in situ: A Dutch population ‐ based study on patients diagnosed between 1999 and 2012. Eur J Cancer. 2018;101:134 ‐ 142. 51. Francis AM, Haugen CE, Grimes LM, Crow JR, Yi M, Mittendorf EA, et al. Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ? Ann Surg Oncol. 2015;22(13):4270 ‐ 4279. 52. Holm ‐ Rasmussen EV, Jensen MB, Balslev E, Kroman N, Tvedskov TF. Risk factors of sentinel and non ‐ sentinel lymph node metastases in patients with ductal carcinoma in situ of the breast: A nationwide study. Breast (Edinburgh, Scotland). 2018;42:128 ‐ 132. 53. van Roozendaal LM, Goorts B, Klinkert M, Keymeulen K, De Vries B, Strobbe LJA, et al. Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy. Breast Cancer Res Treat. 2016;156(3):517 ‐ 525. 54. Zetterlund L, Stemme S, Arnrup H, de Boniface J. Incidence of and risk factors for sentinel lymph node metastasis in patients with a postoperative diagnosis of ductal carcinoma in situ. Br J Surg. 2014;101(5):488 ‐ 494. 55. Magnoni F, Massari G, Santomauro G, Bagnardi V, Pagan E, Peruzzotti G, et al. Sentinel lymph node biopsy in microinvasive ductal carcinoma in situ. Br J Surg. 2019;106(4):375 ‐ 383. 56. Erbas B, Provenzano E, Armes J, Gertig D. The natural history of ductal carcinoma in situ of the breast: a review. Breast Cancer Res Treat. 2006;97(2):135 ‐ 144.